Pharmacogenomic Testing in Children: Which Tests and What Comes After Testing?

In this featurette from the 2021 Midyear Clinical Meeting, our content matter experts from St. Judes Children’s Research Hospital and Boston Children’s Hospital share how their organizations have integrated pharmacogenomics into their programs including pre-emptive testing, identifying drug-gene pairs, integration into the electronic medical records and addressing the familial implications of pharmacogenomic testing.    The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

There are no comments yet.

Please log in to write the first comment.